Seiryu UjiieHead of Purification Technology Development Group at Chugai Pharmaceutical Co., Ltd.Speaker
Profile
Seiryu Ujiie serves as head of the purification technology development group at Chugai Pharmaceutical Co., Ltd., bringing over 15 years of extensive experience and deep expertise in therapeutic antibody manufacturing process development. Since joining Chugai in 2009, he has been consistently involved in antibody process development, accumulating broad experience across innovative antibody-derived product process design, validation studies, scale-up, and GMP manufacturing. Specializing in purification process development, he focuses on developing and implementing innovative solutions to enhance production process efficiency and scalability. While concentrating on building new technological foundations that go beyond conventional approaches, he actively supports the career development of diverse team members and demonstrates cross-functional team leadership, contributing to both technological advancement and talent development.
Agenda Sessions
Keynote Address: Reboot and Go Beyond: Advancing Antibody Purification Process Design
, 10:45View Session